Last reviewed · How we verify

The VERISMART Trial

NCT02490033 NA COMPLETED

Catheter ablation is now routinely used in the management of heart rhythm disorders. One of the problems with the approach is that it has not been possible to determine whether the ablation catheter is in direct contact with the heart tissue or not. This is important because too much contact has safety implications and too little means that the therapy will be ineffective. Recently two different technologies have been developed to determine contact. Currently it is not know if one is superior to the other, and the objective of this trial is to determine whether there is a difference when treating a rhythm called atrial flutter.

Details

Lead sponsorThe Leeds Teaching Hospitals NHS Trust
PhaseNA
StatusCOMPLETED
Enrolment133
Start dateWed Apr 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionSun Oct 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

United Kingdom